Home > News > MBCN in the News

Click on title to read the full article.

Research Unravels New Ways to Treat HER2-Positive Breast Cancer

August 10, 2012

By Elizabeth Whittington, Cure

Perjeta and an increasing arsenal of investigational agents, combinations could significantly improve survival rates in HER2-positive breast cancer.

When Debra Tincher received a diagnosis of stage 2 breast cancer in 1997, testing for HER2-positive breast cancer wasn't standard. She went through treatment and was cancer-free for more than 10 years, teaching kindergarten in Hamilton, Ohio.

 

 

Suzanne Imondi: A Passionate Advocate For Cancer Patients

July 16, 2012

By By ERIC VO, The Hartford Courant

Dr. Suzanne Hebert Imondi, the mother of two children, was known for putting her family's needs before her own. She was always ready to help her children, Dominic and Grace, with homework or whatever they needed.

Imondi, an optometrist, was also devoted to fighting for better treatment and a cure for metastatic breast cancer - hoping to help the many people who, like herself, were diagnosed with the disease.

 

Interrupting Cancer's Travel Plans

May 1, 2012

By Stephen Ornes, Cancer Today

Randy Watnick?s pursuit of a better drug against metastatic cancer began late at night in early 2005. His infant daughter had woken up in tears at their home in Newton, Mass., near Boston. The molecular biologist climbed out of bed, scooped up the sobbing baby, and helped her get back to sleep. Normally able to maintain a healthy distance between work and family, Watnick was unable to fend off thoughts about tumor biology.

For individuals with metastatic disease, when hope arrives, it arrives in “these very tiny increments,” says Suzanne Hebert, the vice president of the Metastatic Breast Cancer Network, an organization that strives to raise awareness of metastatic patients’ needs. In 2004, Hebert was diagnosed with stage IV breast cancer. She says she’s “guarded” when she hears news about new treatments for metastatic disease.

Patient discusses clinical trial for advanced breast cancer

February 28, 2012

By SciVee.com MD Anderson

Seven years ago, Suzanne Hebert was diagnosed with metastatic breast cancer that spread to her liver and bones. After four rounds of chemotherapy and decreasing response rates, she decided it was time for a change. That change came after advice from a friend, who also had advanced breast cancer, and was enrolled on a clinical trial at MD Anderson.

Trials Show Improved Outcome in Metastatic Breast Cancer Patients

December 12, 2011

By Mikaela Conley, ABC Nightly News

For seven years, Suzanne Hebert has undergone treatments, surgeries and chemotherapies to fight off her stage 4 breast cancer. She was diagnosed with the advanced stage cancer at age 39.

After years of chemotherapy treatments, a mastectomy and hormonal therapy -- during which not only was she "miserable, [but] the treatment wasn't working" -- Hebert joined a phase1 clinical trial out of MD Anderson in Texas, where researchers put her on a combined treatment of everolimus, a drug used to treat kidney and brain tumors, and arimidex, an anti-hormone therapy that decreases the amount of estrogen in the body.

Drugs Keep Tumors at Bay

December 8, 2011

By Ron Winslow, Wall Street Journal Online

SAN ANTONIO—Two drugs significantly extend the time that women with metastatic breast cancer can live without their tumors growing, potentially changing the landscape for 80% of patients with the disease, according to two separate studies released Wednesday.

....But Suzanne Hebert, 46 years old, of South Windsor, Conn., said that adding Afinitor to her treatment in another clinical trial appeared to shrink her tumor by 21% after three months.

Katherine’s story: Living with metastatic breast cancer

October 13, 2011

By Laura Woodin, AZ Health Connections

As we explained here, during National Breast Cancer Awareness Month we are focusing on people who are living with metastatic breast cancer.

Katherine O’Brien is a business-to-business editor from Chicago and a volunteer with the Metastatic Breast Cancer Network (MBCN) who contributed the following blog post about her experience with metastatic breast cancer:

At a 2009 breast cancer seminar, I met two MBCN volunteers: Joani Gudeman and Shirley Mertz. I had never met another person with metastatic breast cancer. Joani and Shirley made me feel less alone. Their activism inspired me.

October 13 is National Metastatic Breast Cancer Awareness Day

October 13, 2011

By Coping Magazine

Do you know the 13 facts about metastatic breast cancer?

Leaders in the Fight Against Breast Cancer

October 6, 2011

By The White House

This year, 230,000 women will be diagnosed with Breast Cancer. To kick off Breast Cancer awareness month, we brought in 15 “Champions of Change” who are leaders in the fight to end breast cancer. They represent activists, scientists and health care providers who are making a difference in this fight every day.

MBCN editor's note: We are proud that MBCN member Shirley A. Mertz has been recognized for her "passion and focus as a breast cancer activist, a voice for the needs of those who today are suffering with advanced or Stage IV breast cancer and those who one day will receive such a diagnosis"

Women with metastatic breast cancer clamor for a different awareness level this month

October 5, 2011

By Gary Schwitzer, Publisher, HealthNewsReview.org

Some breast cancer voices raise questions about simply raising "awareness" about breast cancer in October.

Some of them believe that raising awareness about screening, for example, should not be the only message or even the main message of the month.

Katherine O'Brien, who has metastatic breast cancer (MBC), and who publishes the iihatebreastcancer blog refers to being caught in "October's pink undertow."

 < 1 2 3 4 5 >  Last ›